Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 12/12/16 (What's New)

Summary

  • HCC diagnosis should be suspected in individuals with underlying liver disease who develop rising serum AFP
  • HIV-infected patients with cirrhosis and HBV or HCV coinfection should be screened according to AASLD practice guidelines for non-HIV-infected patients, with hepatic ultrasound and AFP measurement at 6 to 12 monthly intervals [guideline: Mgmt of HCC][Phillips 2009; Bruix 2010]
  • Degree of cirrhosis should be assessed before definitive treatment using Child-Pugh classification

Action required